BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38054817)

  • 41. Gegen Qinlian decoction ameliorates TNBS-induced ulcerative colitis by regulating Th2/Th1 and Tregs/Th17 cells balance, inhibiting NLRP3 inflammasome activation and reshaping gut microbiota.
    Hu Y; Tang J; Xie Y; Xu W; Zhu W; Xia L; Fang J; Yu D; Liu J; Zheng Z; Zhou Q; Shou Q; Zhang W
    J Ethnopharmacol; 2024 Jun; 328():117956. PubMed ID: 38428658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction.
    Boini KM; Hussain T; Li PL; Koka S
    Cell Physiol Biochem; 2017; 44(1):152-162. PubMed ID: 29130962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway.
    Qian W; Cai X; Qian Q; Zhuang Q; Yang W; Zhang X; Zhao L
    Drug Des Devel Ther; 2019; 13():2579-2589. PubMed ID: 31440038
    [No Abstract]   [Full Text] [Related]  

  • 44. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
    Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NLRP3-inflammasome inhibition by MCC950 attenuates cardiac and pulmonary artery remodelling in heart failure with preserved ejection fraction.
    Cheng X; Zhao H; Wen X; Li G; Guo S; Zhang D
    Life Sci; 2023 Nov; 333():122185. PubMed ID: 37858713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vildagliptin inhibits high free fatty acid (FFA)-induced NLRP3 inflammasome activation in endothelial cells.
    Qi Y; Du X; Yao X; Zhao Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1067-1074. PubMed ID: 30945564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.
    Xu X; Huang X; Zhang L; Huang X; Qin Z; Hua F
    BMC Nephrol; 2021 Jun; 22(1):218. PubMed ID: 34107901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis.
    Guo S; Wang L; Cao K; Li Z; Song M; Huang S; Li Z; Wang C; Chen P; Wang Y; Dai X; Chen X; Fu X; Feng D; He J; Huo Y; Xu Y
    Cardiovasc Res; 2024 Jul; 120(8):883-898. PubMed ID: 38626254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effects of Acute and Chronic Aerobic Activity on the Signaling Pathway of the Inflammasome NLRP3 Complex in Young Men.
    Khakroo Abkenar I; Rahmani-Nia F; Lombardi G
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30991661
    [No Abstract]   [Full Text] [Related]  

  • 51. MLKL Aggravates Ox-LDL-Induced Cell Pyroptosis via Activation of NLRP3 Inflammasome in Human Umbilical Vein Endothelial Cells.
    Wu Q; He X; Wu LM; Zhang RY; Li LM; Wu CM; Lu YB; Hu B; Shi C; Lu ZF; Yang B; Zheng L; Hu YW; Wang Q
    Inflammation; 2020 Dec; 43(6):2222-2231. PubMed ID: 32621119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meteorin-like/Meteorin-β Is a Novel Immunoregulatory Cytokine Associated with Inflammation.
    Ushach I; Arrevillaga-Boni G; Heller GN; Pone E; Hernandez-Ruiz M; Catalan-Dibene J; Hevezi P; Zlotnik A
    J Immunol; 2018 Dec; 201(12):3669-3676. PubMed ID: 30464051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells.
    Villacampa A; Alfaro E; Morales C; Díaz-García E; López-Fernández C; Bartha JL; López-Sánchez F; Lorenzo Ó; Moncada S; Sánchez-Ferrer CF; García-Río F; Cubillos-Zapata C; Peiró C
    Cell Commun Signal; 2024 Jan; 22(1):38. PubMed ID: 38225643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trophoblastic mitochondrial DNA induces endothelial dysfunction and NLRP3 inflammasome activation: Implications for preeclampsia.
    Lv Z; Lv DY; Meng JY; Sha XY; Qian XY; Chen YS; Pan XY; Yu GY; Liu HS
    Int Immunopharmacol; 2023 Jan; 114():109523. PubMed ID: 36508916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome.
    Shen Q; Chen Y; Shi J; Pei C; Chen S; Huang S; Li W; Shi X; Liang J; Hou S
    Eur J Pharmacol; 2023 Mar; 942():175504. PubMed ID: 36641101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atox1 regulates macrophage polarization in intestinal inflammation via ROS-NLRP3 inflammasome pathway.
    Chen M; Chen Y; Fu R; Liu S; Li H; Shen T
    J Transl Med; 2024 May; 22(1):497. PubMed ID: 38796413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.
    Zhang X; Wang Z; Li X; Chen J; Yu Z; Li X; Sun C; Hu L; Wu M; Liu L
    J Ethnopharmacol; 2023 Jun; 309():116304. PubMed ID: 36870461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition.
    Satish M; Agrawal DK
    Transl Res; 2020 Jan; 215():75-85. PubMed ID: 31469975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
    Hettwer J; Hinterdobler J; Miritsch B; Deutsch MA; Li X; Mauersberger C; Moggio A; Braster Q; Gram H; Robertson AAB; Cooper MA; Groß O; Krane M; Weber C; Koenig W; Soehnlein O; Adamstein NH; Ridker P; Schunkert H; Libby P; Kessler T; Sager HB
    Cardiovasc Res; 2022 Oct; 118(13):2778-2791. PubMed ID: 34718444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activation.
    Shamoon L; Espitia-Corredor JA; Dongil P; Menéndez-Ribes M; Romero A; Valencia I; Díaz-Araya G; Sánchez-Ferrer CF; Peiró C
    Biochem Pharmacol; 2022 Jul; 201():115078. PubMed ID: 35551917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.